# Prescription Use Blood Glucose Meter For Near-Patient Testing
> **Product code: PZI** · Class II — Moderate Risk (510(k) clearance required) · Clinical Chemistry · 21 CFR 862.1345
## Classification
- **FDA Product Code:** PZI
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 862.1345
- **Review panel:** CH
- **Medical specialty:** Clinical Chemistry
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

Intended for use in near-patient testing settings for in vitro diagnostic, multiple-patient use for the quantitative determination of glucose throughout all hospital and all professional healthcare settings for use in determining dysglycemia.

## Market data
- **Cleared 510(k) submissions:** 13
- **Registered establishments:** 8
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=PZI)
---
*AI Analytics · CC0 1.0*